111, Inc.
YI- Exchange
- Nasdaq
- Industry
- Retail-Drug Stores and Proprietary Stores
- SEC CIK
- 0001738906
In the last 90 days, 111, Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $498.4K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in 111, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −3 vs. Q1 2023
- Shares held
- 1.82M
- −61.5K (−3.3%) vs. Q1 2023
- Total value
- $4.46M
- −$508.7K (−10.2%) vs. Q1 2023
- New holders
- 1
- 6 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $498.4K |
| Q1 2026 | 8 | $410.3K |
| Q4 2025 | 9 | $466.4K |
| Q3 2025 | 8 | $540.8K |
| Q2 2025 | 9 | $661.0K |
| Q1 2025 | 9 | $625.9K |
| Q4 2024 | 20 | $2.23M |
| Q3 2024 | 9 | $241.8K |
| Q2 2024 | 15 | $2.26M |
| Q1 2024 | 16 | $2.19M |
| Q4 2023 | 17 | $3.03M |
| Q3 2023 | 14 | $4.99M |
| Q2 2023 | 13 | $4.46M |
| Q1 2023 | 16 | $4.97M |
| Q4 2022 | 17 | $6.14M |
| Q3 2022 | 16 | $8.84M |
| Q2 2022 | 15 | $6.93M |
| Q1 2022 | 19 | $9.51M |
| Q4 2021 | 23 | $13.6M |
| Q3 2021 | 23 | $24.2M |
| Q2 2021 | 29 | $50.5M |
| Q1 2021 | 33 | $70.1M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding 111, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 724,917 | $1.78M | 0.00% | −8,228−1.1% | Reduced |
| Greenwoods Asset Management Hong Kong Ltd.SuperinvestorGreenwoods Asset Management | 348,863 | $858.1K | 0.04% | 00.0% | Unchanged |
| Barclays PLC | 329,800 | $811.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 151,347 | $372.0K | 0.00% | +40,000+35.9% | Added |
| State Street Corp | 93,231 | $229.3K | 0.00% | +5,562+6.3% | Added |
| Prelude Capital Management, LLC | 48,500 | $119.3K | 0.01% | +1,500+3.2% | Added |
| Geode Capital Management, LLC | 33,100 | $81.4K | 0.00% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 30,983 | $76.2K | 0.00% | +1,867+6.4% | Added |
| Citadel Advisors LLC | 26,664 | $65.6K | 0.00% | −15,400−36.6% | Reduced |
| Morgan Stanley | 11,100 | $27.3K | 0.00% | +958+9.4% | Added |
| Tower Research Capital LLC (TRC) | 10,339 | $25.4K | 0.00% | +4,789+86.3% | Added |
| Rhumbline Advisers | 5,245 | $12.9K | 0.00% | +5,245 | New |
| Wellspring Financial Advisors, LLC | 4,300 | – | – | 00.0% | Unchanged |
| Invesco Ltd. | 0 | $0 | 0.00% | −56,068−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −23,536−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −692−100.0% | Sold out |